Kintara Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kintara Therapeutics generated cash of -$7,176,000, which is more than the previous year. Cash used in financing activities reached the amount of $10,570,000 last year. Net change in cash is therefore $3,374,000.
Cash Flow
| 2015 | -3.85M | 0 | 847.79K |
|---|---|---|---|
| 2016 | -5.14M | -16.76K | 9.56M |
| 2017 | -8.01M | -20.95K | 8.46M |
| 2018 | -9.85M | -12.64K | 9.24M |
| 2019 | -6.32M | 0 | 4.07M |
| 2020 | -7.92M | 0 | 6.60K |
| 2021 | -18.86M | 964K | 26.04M |
| 2022 | -20.39M | 964K | 21.63M |
| 2023 | -11.86M | -232K | 1.85M |
| 2024 | -7.17M | -20K | 10.57M |
KTRA Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.53M | 11.78M | 10.53M | 2.39M | 3.71M | 5.97M | 6.58M | 6.15M | 1.75M | 4.75M |
Operating activities | ||||||||||
Net income | -8.32M | -14.64M | -22.66M | -38.29M | -9.12M | -8.04M | -11.13M | -8.08M | -8.86M | -4.79M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 55K | 60K | 60K | 32K | 9.95K | 16.34K | 24.52K | 16.68K | 10.28K | 0 |
Stock-based compensation expense | 607K | 1.49M | 2.24M | 5.27M | 495K | 952.17K | 544.54K | 124.74K | 394.13K | 368.08K |
| Deferred income tax benefit | 607K | 1.49M | 2.24M | 5.27M | 495K | 952.17K | 544.54K | 124.74K | 394.13K | 368.08K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 16.78K | 13.33K | 37.07K | -58.20K | 7.44K | 0 |
Inventories | 0 | 0 | 0 | 0 | -16.78K | -13.33K | 0 | 0 | 0 | 0 |
Accounts payable | -577K | -442K | 1.00M | -67K | 206.59K | 202K | 295.77K | 598.31K | -178.26K | 517.35K |
Cash generated by operating activities | -7.17M | -11.86M | -20.39M | -18.86M | -7.92M | -6.32M | -9.85M | -8.01M | -5.14M | -3.85M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -20K | -232K | 0 | -8K | 0 | 0 | -12.64K | -20.95K | -16.76K | 0 |
Acquisitions Net | 0 | 0 | 0 | 969K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -20K | -232K | 964K | 964K | 0 | 0 | -12.64K | -20.95K | -16.76K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 10.57M | 1.90M | 21.56M | 21.59M | 6.63M | 3.36M | 8.94M | 7.93M | 2.45M | 0 |
Payments for dividends | -6K | -8K | -8K | -8K | -8K | -8.35K | -8.35K | -8.35K | -8.35K | -6.26K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -500K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 10.57M | 1.85M | 21.63M | 26.04M | 6.60K | 4.07M | 9.24M | 8.46M | 9.56M | 847.79K |
Net Change In Cash | 3.37M | -10.24M | 1.24M | 8.14M | -1.32M | -2.25M | -614.01K | 428.75K | 4.40M | -3.00M |
Cash at end of period | 4.90M | 1.53M | 11.78M | 10.53M | 2.39M | 3.71M | 5.97M | 6.58M | 6.15M | 1.75M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |